• Type:
  • Category:

Carl Zeiss Meditec AG Financial Results Q1 2022 / 23 | Unlocking the Stellar Performance with CEO


Carl Zeiss Meditec AG Q1 2022/23: Key Takeaways

Unlock the Secrets Behind Carl Zeiss Meditec’s Stellar Q1-2022/23 Financial Results

Join Markus Weber, CEO, and Justus Felix Wehmer, CFO, as they navigate the key highlights and insights from the Q1-2022/23 financial presentation. Discover the latest updates on the company’s revenue growth, operating results, and future projections.


Explore Carl Zeiss Meditec’s Robust Financial Growth

Witness formidable growth with revenue surging by 14.6% (adjusted for currency effects: +12.1%). Despite encountering hurdles, the dedicated team at Carl Zeiss has significantly reduced customer delivery times and perpetuated investment in propelling future growth.


Contribution of Strategic Business Units to Growth

Ophthalmology and Microsurgery Units Drive Expansion

The Ophthalmology and Microsurgery strategic business units have markedly contributed to the growth, recording substantial growth rates across all regions. Although the operating result was dampened due to escalated operating costs and a less favourable product mix than the prior year, the future business trajectory in 2022/23 maintains a positive tilt. With an anticipation of continued market and revenue growth, the company is poised to mirror or surpass market dynamism.


Sustaining Growth: Investments in Multiple Domains

Carl Zeiss Meditec AG underscores a continuous investment strategy in sales, marketing, and research and development. This ensures the periodic launch of innovative products and groundbreaking innovations, thereby scripting the future chapters of the company with sustained growth and technological advancement.


CEO Markus Weber on Investing in Future Growth

In the words of CEO Markus Weber, “Our team is pulling out all the stops to reduce delivery time for our customers. Simultaneously, we remain committed to ceaseless investment in our future growth.”


Be a Part of Carl Zeiss Meditec’s Financial Presentation

Ensure you take advantage of this enlightening financial presentation. Be part of the journey and attend the presentation, available at seat11a!


Dr. Markus Weber
CEO | Carl Zeiss Meditec AG

Justus Felix Wehmer
CFO | Carl Zeiss Meditec AG

Sebastian Frericks
Head IR | Carl Zeiss Meditec AG


This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/

Discover Additional Elevator Pitches

Reviews for Carl Zeiss Meditec AG Financial Results Q1 2022 / 23 | Unlocking the Stellar Performance with CEO
There are currently no reviews for Carl Zeiss Meditec AG Financial Results Q1 2022 / 23 | Unlocking the Stellar Performance with CEO
Scroll to top